AMA Corporation Plc (ALAMA) AI Stock Analysis

AMA Corporation Plc

(Paris:ALAMA)

Select Model

Rating:40Underperform

Price Target:EUR 0.09▼(-4.44% Downside)

Action:downgraded

Date:10/07/26

Primarily driven by critically weak financial performance with declining revenues, losses, and negative equity; bearish technical indicators and unfavorable valuation metrics add further pressure.

Positive Factors

Strong Gross MarginA strong gross margin indicates that AMA retains meaningful economics on the services it sells, providing a foundation for improvement if operating costs can be brought under control. This supports the potential for better earnings conversion over the next several quarters, although current losses remain substantial.

Negative Factors

Persistent UnprofitabilityOngoing operating and net losses show that the business has not yet converted its revenue base into sustainable earnings. Continued losses can consume capital, restrict investment capacity, and make a durable path to self-funded growth more difficult unless operating costs decline materially.

AMA Corporation Plc (ALAMA) vs. iShares MSCI France ETF (EWQ)

Market Cap: EUR 4.82M
Dividend Yield: ―
Average Volume (3M): 22.33K
Price to Earnings (P/E): -0.6
Beta (1Y): 1.14
Revenue Growth: -20.28%
EPS Growth: 22.97%
Country: France
Employees: 27
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Healthcare Information Services

AMA Corporation Plc Business Overview & Revenue Model

Company Description

AMA Corporation Ltd delivers remote support solutions to industrial organizations, service providers, and medical institutions across the globe. The company develops its XpertEye assisted reality platform, which facilitates applications like remote g...

How the Company Makes Money

null

AMA Corporation Plc Financial Statement Overview

Summary

Severe weaknesses with declining revenues, persistent net losses, negative equity, and ongoing cash burn signal high financial distress.

Income Statement

15Very Negative

Balance Sheet

10Very Negative

Cash Flow

12Very Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.99M	1.99M	2.49M	3.01M	4.28M	6.57M
Gross Profit	1.42M	1.42M	1.97M	-688.00K	4.90M	8.04M
EBITDA	-4.99M	-4.99M	-6.36M	-6.87M	-10.27M	-6.52M
Net Income	-5.67M	-5.67M	-7.34M	-8.04M	-21.39M	-9.84M
Balance Sheet
Total Assets	4.43M	4.43M	9.17M	12.75M	13.65M	38.22M
Cash, Cash Equivalents and Short-Term Investments	2.09M	2.09M	5.82M	9.39M	8.60M	20.64M
Total Debt	2.79M	2.79M	4.03M	3.96M	4.53M	4.70M
Total Liabilities	5.37M	5.37M	6.62M	6.97M	7.85M	11.32M
Stockholders Equity	-991.00K	-991.00K	2.50M	5.71M	5.68M	27.29M
Cash Flow
Free Cash Flow	-4.84M	-4.84M	-6.39M	-5.79M	-13.00M	-10.28M
Operating Cash Flow	-4.80M	-4.80M	-6.28M	-5.74M	-10.52M	-5.10M
Investing Cash Flow	37.00K	37.00K	114.00K	149.00K	-1.24M	-5.22M
Financing Cash Flow	1.06M	1.06M	2.59M	6.46M	-293.00K	29.67M

AMA Corporation Plc Technical Analysis

Technical Analysis SentimentNegative

Last Price0.09

Price Trends

50DMA0.14Negative

100DMA0.14Negative

200DMA0.13Negative

Market Momentum

MACD-0.01Negative

RSI32.61Neutral

STOCH62.68Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALAMA, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.14, and below the 200-day MA of 0.13, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 32.61 is Neutral, neither overbought nor oversold. The STOCH value of 62.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALAMA.

AMA Corporation Plc Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

FR:ALAMA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:ALERS	58Neutral	EUR 258.39M	37.57	3.89%	―	6.28%	204.56%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
FR:ALIKO	46Neutral	EUR 22.42M	-5.16	-22.03%	―	37.28%	7.83%
FR:ALMDT	43Neutral	EUR 180.85M	-2.87	271.64%	―	2.16%	-5.26%
FR:ALAMA	40Underperform	EUR 5.30M	-0.60	―	―	-20.28%	22.97%

* Healthcare Sector Average

Performance Comparison

FR:ALAMA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
FR:ALAMA	AMA Corporation Plc	0.09	-0.08	-47.06%
FR:ALERS	Eurobio-Scientific SA	26.30	2.15	8.90%
FR:ALDMS	Diagnostic Medical Systems	0.91	-0.41	-31.06%
FR:ALIKO	Ikonisys SA	1.41	-0.05	-3.42%
FR:ALMDT	Median Technologies	3.53	0.55	18.66%
FR:ALBIO	Biosynex SA	0.84	0.26	44.33%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 07, 2026

AMA Corporation Plc AI Stock Analysis